Alan is also engaged in a broad range of research projects and programs, including the Berman Institute’s science programs: the Stem Cell Policy and Ethics (SCOPE) Program; the Program in Ethics and Brain Sciences (PEBS-Neuroethics); and the Hinxton Group, an international consortium on stem cells, ethics and law; and the eSchool+ Initiative. Recent research has focused on using deliberative democracy tools to engage with communities about their values for allocating scarce medical resources like ventilators in disasters like pandemics. Additional recent work has focused on ethical challenges related to gene editing, stem cell research, social media, public engagement, vaccines, and neuroethics. (Publications)
Zackary Berger, MD, PhD
Dr. Berger is Associate Professor in the Johns Hopkins Division of General Internal Medicine and Core Faculty at the Johns Hopkins Berman Institute of Bioethics, with joint appointment in the Johns Hopkins Bloomberg School of Public Health. With an active practice in primary care internal medicine at Johns Hopkins, Dr. Berger focuses his clinical, educational, and research work, as well as his widely read publications for the lay public, on the ways in which shared decision making in the doctor-patient encounter might be in conflict with medical evidence and the political, social, and psychological realities of the patient.
Dr. Berger teaches residents in their internal medicine clinic and medical students on the wards at Johns Hopkins Hospital, and is part of a Berman faculty team which teaches bioethics to residents in a number of Johns Hopkins specialty programs. He is also staff physician at the Esperanza Clinic Health Center, a free clinic serving undocumented Spanish-speaking immigrants.
Dr. Berger is the author of two books for the lay public on doctor-patient communication and on patient preference in the context of medical evidence.
Hilary Bok, PhD
Jeremy Sugarman, MD, MPH, MA
He was the founding director of the Trent Center for Bioethics, Humanities and History of Medicine at Duke University where he was also a professor of medicine and philosophy. He was appointed as an Academic Icon at the University of Malaya and is a faculty affiliate of the Kennedy Institute of Ethics at Georgetown University.
Dr. Sugarman was the longstanding chair of the Ethics Working Group of the HIV Prevention Trials Network. He is currently a member of the Scientific and Research Advisory Board for the Canadian Blood Service and the Ethics and Public Policy Committees of the International Society for Stem Cell Research. He co-leads the Ethics and Regulatory Core of the NIH Health Care Systems Research Collaboratory and is co-chair of the Johns Hopkins’ Institutional Stem Cell Research Oversight Committee.
Dr. Sugarman has been elected as a member of the American Society of Clinical Investigation, Association of American Physicians, and the National Academy of Medicine (formerly the Institute of Medicine). He is a fellow of the American Association for the Advancement of Science, the American College of Physicians and the Hastings Center. He also received a Doctor of Science, honoris causa, from New York Medical College.
Ruth R. Faden, PhD, MPH
Ruth R. Faden, PhD, MPH, is the founder of the Johns Hopkins Berman Institute of Bioethics. She was the Berman Institute’s Director from 1995 until 2016, and the inaugural Andreas C. Dracopoulos Director (2014-2016). Dr. Faden was, and is currently, the inaugural Philip Franklin Wagley Professor of Biomedical Ethics. In the twenty years in which Dr. Faden led the Berman Institute, she transformed what was an informal interest group of faculty across Johns Hopkins into a one of the world’s premier bioethics programs with over 35 faculty, 30 staff and over 100 alumni. Under her direction, the Berman Institute became a universitywide unit of Johns Hopkins with its own building, reporting to the Provost. Dr. Faden also secured a significant endowment for the Berman Institute, including six endowed professorships and an endowed directorship.
Dr. Faden is a leading scholar in the field of bioethics. She is the author and editor of numerous books and many articles on biomedical ethics and public policy, including most significantly Social Justice: The Moral Foundations of Public Health and Health Policy (with Madison Powers), A History and Theory of Informed Consent (with Tom L. Beauchamp), Structural Injustice: Power, Advantage, and Human Rights (with Madison Powers; forthcoming, Oxford University Press).
Dr. Faden’s current research focuses on structural justice theory, and on national and global challenges in food and agriculture, learning health care systems, health systems design and priority setting, and access to the benefits of global investments in biomedical research. Dr. Faden also works on ethical challenges in biomedical science, with a particular focus on women’s health and the rights and interests of pregnant women.
Dr. Faden is an elected member of the National Academy of Medicine and a Fellow of the Hastings Center and the American Psychological Association. She has served on numerous national advisory committees and commissions, including President William Clinton’s Advisory Committee on Human Radiation Experiments, which she chaired. Dr. Faden colaunched the Global Food Ethics and Policy Program, sponsor of the 7 by 5 Agenda for Ethics and Global Food Security. She is also a cofounder of the Hinxton Group, a global community committed to advancing ethical and policy challenges in stem cell science, and the Second Wave initiative, an effort to ensure that the health interests of pregnant women are fairly represented in biomedical research and drug and device policies.
In 2011, Dr. Faden was the recipient of Lifetime Achievement Awards from the American Society for Bioethics and Humanities (ASBH) and Public Responsibility in Medicine and Research (PRIMR).
Jeffrey Kahn, PhD, MPH
Prof. Kahn has served on numerous state and federal advisory panels. He was most recently chair of National Academies of Sciences, Engineering, and Medicine’s Board on Health Sciences Policy, and previously chaired its committee on the Use of Chimpanzees in Biomedical and Behavioral Research (2011); the committee on Ethics Principles and Guidelines for Health Standards for Long Duration and Exploration Spaceflights (2014); and a committee on the Ethical, Social, and Policy Considerations of Mitochondrial Replacement Techniques (2016). He also formerly served as a member of the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
In addition to committee leadership and membership, Prof. Kahn is an elected member of the National Academy of Medicine and an elected Fellow of The Hastings Center. He was also the founding president of the Association of Bioethics Program Directors, an office he held from 2006-2010.
Prof. Kahn is a co-principal investigator with Berman Institute faculty member Gail Geller, ScD, MHS, on GUIDE: Genomic Uses in Infectious Disease and Epidemics, an NIH-funded project to study the largely unexplored ethical, legal and social implications (ELSI) of genomics as applied to infectious disease.
Prof. Kahn’s publications include Contemporary Issues in Bioethics; Beyond Consent: Seeking Justice in Research; Ethics of Research With Human Subjects: Selected Policies and Resources; The Oxford Handbook of Public Health Ethics (editor); Digital Contact Tracing for Pandemic Response (editor); as well as more than 125 scholarly and research articles. He also speaks widely across the U.S. and around the world on a range of bioethics topics, in addition to frequent media outreach. From 1998-2002 he wrote the bi-weekly column Ethics Matters on CNN.com. In 2023, he served as executive producer of a bioethics podcast, playing god?
Prior to joining the faculty at Johns Hopkins, Prof. Kahn was Director of the Center for Bioethics at the University of Minnesota.